Generalized Eruptive Keratoacanthoma (GEKA) after Pfizer mRNABNT162b2 (Comirnaty
COVID-19
cemiplimab
generalized eruptive keratoacanthoma
keratoacanthoma
vaccination
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
06 Aug 2024
06 Aug 2024
Historique:
received:
18
07
2024
revised:
02
08
2024
accepted:
04
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
In December 2020, a major vaccination program against COVID-19 commenced in Europe with vaccines such as Pfizer's mRNABNT162b2 (Comirnaty
Identifiants
pubmed: 39205234
pii: v16081260
doi: 10.3390/v16081260
pii:
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
BNT162 Vaccine
0
cemiplimab
6QVL057INT
COVID-19 Vaccines
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM